EUVIMEDEUVIMED entdecken
EvaluationsstudieOpen Access · CC BY 4.0

Evaluating the Prognostic Significance of the H-Index and Systemic Inflammatory Parameters in IDH-Wildtype Glioblastoma Survival

Havva Yeşil iD, Bekir Demirel iD, Ercan Gumusburun iD

Current Oncology · 2026

DOI: 10.3390/curroncol33100604 ↗

Kurz gefasst

Evaluationsstudie in der Zeitschrift Current Oncology, 2026. Verfasst von Havva Yeşil und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Oncology, Faculty of Medicine, Gaziantep University, 27310 Gaziantep, Türkiye. Hauptthemen laut MEDLINE: Brain Neoplasms, Glioblastoma, Health Status Indicators. Die Arbeit nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

IDH-wildtype Glioblastoma is characterized by an aggressive clinical course. This study aimed to evaluate the prognostic value of the H-index, the hemoglobin-albumin-lymphocyte-platelet (HALP) score and the aggregate index of systemic inflammation (AISI).

Methods

We retrospectively analyzed 136 patients who underwent frontline chemoradiotherapy.

Results

Optimal cut-offs were 20.94 for HALP, 2.29 for H-index, and 989.64 for AISI. A high H-index was associated with shorter overall survival (OS) in univariate analysis (p = 0.007) and showed the highest time-dependent AUC for OS among the three indices. In multivariable Cox models, comorbidities (p = 0.043), subtotal resection (p < 0.001), corticosteroid use (p = 0.040), and a low HALP score (p = 0.012) were associated with poor OS, whereas the associations for a high H-index (p = 0.084) and a high AISI (p = 0.036) did not meet the Bonferroni-adjusted significance threshold. In a sensitivity analysis restricted to patients not receiving corticosteroids (n = 80), H-index-based stratification remained associated with OS (median 14.4 vs. 24.9 months, log-rank p = 0.025), whereas the association for AISI was not retained.

Conclusions

The H-index, evaluated here for the first time, and the HALP score may provide complementary prognostic information. Given the retrospective single-center design, the potential influence of corticosteroids, and the data-driven cut-offs, these findings should be regarded as exploratory and require external validation before clinical application.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Brain NeoplasmsGlioblastomaHealth Status IndicatorsPrognosisIsocitrate DehydrogenasePredictive Value of TestsRetrospective StudiesHemoglobinsSerum Albumin, HumanPlatelet CountLymphocyte CountInflammationReference ValuesChemoradiotherapyHumansMaleFemaleAdolescentYoung AdultAdultMiddle AgedAgedAged, 80 and over

Stichwörter der Autor:innen

AISIH-indexHALP scoreIDH-wildtype glioblastomaprognosissystemic inflammation

Substanzen

Isocitrate DehydrogenaseHemoglobinsSerum Albumin, Human

Autor:innen und Institutionen

  • Department of Medical Oncology, Faculty of Medicine, Gaziantep University, 27310 Gaziantep, Türkiye.
  • Department of Internal Medicine, Faculty of Medicine, Gaziantep University, 27310 Gaziantep, Türkiye.

ORCID-Profile: Havva Yeşil, Bekir Demirel, Ercan Gumusburun

Zitieren

APA

Yeşil, H., Demirel, B., & Gumusburun, E. (2026). Evaluating the Prognostic Significance of the H-Index and Systemic Inflammatory Parameters in IDH-Wildtype Glioblastoma Survival. Current Oncology. https://doi.org/10.3390/curroncol33100604

Vancouver

Yeşil H, Demirel B, Gumusburun E. Evaluating the Prognostic Significance of the H-Index and Systemic Inflammatory Parameters in IDH-Wildtype Glioblastoma Survival. Current Oncology. 2026. doi:10.3390/curroncol33100604

BibTeX
@article{Yeil2026,
  author = {Yeşil, Havva and Demirel, Bekir and Gumusburun, Ercan},
  title = {Evaluating the Prognostic Significance of the H-Index and Systemic Inflammatory Parameters in IDH-Wildtype Glioblastoma Survival},
  journal = {Current Oncology},
  year = {2026},
  doi = {10.3390/curroncol33100604}
}
Kostenlos starten →